Genesee Capital Advisors, LLC Astrazeneca PLC Transaction History

Genesee Capital Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 16, 2021	SELL	$47.16 - $54.44 $623,926 - $720,241	-13,230 Closed	0 $0
Q4 2020 Jan 19, 2021	SELL	$48.52 - $58.02 $52,256 - $62,487	-1,077 Reduced 7.53%	13,230 $661,000
Q3 2020 Oct 29, 2020	BUY	$53.07 - $61.1 $8,756 - $10,081	165 Added 1.17%	14,307 $784,000
Q2 2020 Jul 20, 2020	BUY	$43.1 - $55.31 $609,520 - $782,194	14,142 New	14,142 $747,000

1,361

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $200B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Genesee Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Genesee Capital Advisors, LLC with notifications on news.